Activation Mechanism of Anticoagulant Protein C in Large Blood Vessels Involving the Endothelial Cell Protein C Receptor
Open Access
- 6 April 1998
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 187 (7) , 1029-1035
- https://doi.org/10.1084/jem.187.7.1029
Abstract
Protein C is an important regulatory mechanism of blood coagulation. Protein C functions as an anticoagulant when converted to the active serine protease form on the endothelial cell surface. Thrombomodulin (TM), an endothelial cell surface receptor specific for thrombin, has been identified as an essential component for protein C activation. Although protein C can be activated directly by the thrombin–TM complex, the conversion is known as a relatively low-affinity reaction. Therefore, protein C activation has been believed to occur only in microcirculation. On the other hand, we have identified and cloned a novel endothelial cell surface receptor (EPCR) that is capable of high-affinity binding of protein C and activated protein C. In this study, we demonstrate the constitutive, endothelial cell–specific expression of EPCR in vivo. Abundant expression was particularly detected in the aorta and large arteries. In vitro cultured, arterial endothelial cells were also found to express abundant EPCR and were capable of promoting significant levels of protein C activation. EPCR was found to greatly accelerate protein C activation by examining functional activity in transfected cell lines expressing EPCR and/or TM. EPCR decreased the dissociation constant and increased the maximum velocity for protein C activation mediated by the thrombin–TM complex. By these mechanisms, EPCR appears to enable significant levels of protein C activation in large vessels. These results suggest that the protein C anticoagulation pathway is important for the regulation of blood coagulation not only in microvessels but also in large vessels.Keywords
This publication has 35 references indexed in Scilit:
- The Endothelial Cell Protein C ReceptorJournal of Biological Chemistry, 1996
- Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.Journal of Clinical Investigation, 1994
- Accelerated brain infarction in hypertension complicated by hereditary heterozygous protein C deficiency.Stroke, 1993
- Arterial thrombosis as clinical manifestation of congenital protein C deficiencyAnnals of Hematology, 1991
- Ischemic stroke due to protein C deficiency.Stroke, 1990
- Absence of Thrombosis in Subjects with Heterozygous Protein C DeficiencyNew England Journal of Medicine, 1987
- Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor.Proceedings of the National Academy of Sciences, 1986
- Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.The Journal of cell biology, 1985
- Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.Proceedings of the National Academy of Sciences, 1981
- Anticoagulant properties of bovine plasma protein C following activation by thrombinBiochemistry, 1977